Remedium Lifecare [REMLIFE] vs Divi's Laboratories [DIVISLAB] Detailed Stock Comparison

Remedium Lifecare

BSE
Loading...

Divi's Laboratories

NSE
Loading...

TLDR: Quick Comparison Summary

Based on 20 vital metrics comparison: Remedium Lifecare wins in 5 metrics, Divi's Laboratories wins in 14 metrics, with 0 ties. Divi's Laboratories appears stronger overall.

View Metrics Details

Vital Metrics Comparison

MetricRemedium LifecareDivi's LaboratoriesBetter
P/E Ratio (TTM)25.1769.80Remedium Lifecare
Price-to-Book Ratio1.4110.74Remedium Lifecare
Debt-to-Equity Ratio2,600.510.03Divi's Laboratories
PEG Ratio0.322.64Remedium Lifecare
EV/EBITDA3,209.7351.05Divi's Laboratories
Profit Margin (TTM)1.17%23.89%Divi's Laboratories
Operating Margin (TTM)1.65%25.60%Divi's Laboratories
EBITDA Margin (TTM)1.65%25.60%Divi's Laboratories
Return on Equity4.85%14.64%Divi's Laboratories
Return on Assets (TTM)0.12%12.94%Divi's Laboratories
Free Cash Flow (TTM)$-11.44B$2.15BDivi's Laboratories
Dividend YieldN/A0.91%N/A
1-Year Return-83.46%12.13%Divi's Laboratories
Price-to-Sales Ratio (TTM)0.3016.66Remedium Lifecare
Enterprise Value$12.80B$1,564.62BDivi's Laboratories
EV/Revenue Ratio2.9016.21Remedium Lifecare
Gross Profit Margin (TTM)4.88%60.33%Divi's Laboratories
Revenue per Share (TTM)$8$363Divi's Laboratories
Earnings per Share (Diluted)$0.06$86.78Divi's Laboratories
Beta (Stock Volatility)1.200.23Divi's Laboratories
Performance
News Sentiment
Key Stats
Valuation
Financials
Short Interest
Dividends

Remedium Lifecare vs Divi's Laboratories Stock Performance Analysis

Loading Price Chart...

Remedium Lifecare
Divi's Laboratories
Remedium Lifecare Stock Overview | Divi's Laboratories Stock Overview

Performance Comparison

Short-term Returns

Stock1D1W1M3M6MYTD
Remedium Lifecare0.00%-1.32%14.50%57.89%-29.58%-70.41%
Divi's Laboratories1.00%1.60%-0.85%-6.67%7.78%0.64%

Long-term Returns

Stock1Y3Y5Y10Y15Y20Y
Remedium Lifecare-83.46%-98.90%-96.94%-96.94%-96.94%-96.94%
Divi's Laboratories12.13%67.79%99.69%445.03%1,617.10%8,875.04%

News Based Sentiment: Remedium Lifecare vs Divi's Laboratories

Remedium Lifecare

News based Sentiment: POSITIVE

Remedium Lifecare experienced a significant month with a major contract win in the UK and approval for a substantial rights issue. These developments, coupled with positive Q1 FY26 results, suggest a potential turning point for the company and a strengthening investment case, despite some insider selling activity.

View Remedium Lifecare News Sentiment Analysis

Divi's Laboratories

News based Sentiment: MIXED

September presented a mixed bag for Divi's Laboratories, with sequential declines in financial performance and a downgrade offset by continued strength in custom synthesis and a positive outlook from Jefferies. The insider selling and neutral analyst rating add to the complexity, making it a significant but uncertain month for investors.

View Divi's Laboratories News Sentiment Analysis

Performance & Financial Health Analysis: Remedium Lifecare vs Divi's Laboratories

MetricREMLIFEDIVISLAB
Market Information
Market Cap i₹1.33B₹1.62T
Market Cap CategorySmall capLarge cap
10 Day Avg. Volume i13,810,708357,978
90 Day Avg. Volume i8,468,759424,293
Last Close₹1.50₹6,112.00
52 Week Range₹0.80 - ₹9.34₹4,955.00 - ₹7,071.50
% from 52W High-83.94%-13.57%
All-Time High₹4,547.80 (Jul 03, 2023)₹7,071.50 (Jul 08, 2025)
% from All-Time High-99.97%-13.57%
Growth Metrics
Quarterly Revenue Growth0.46%0.14%
Quarterly Earnings Growth1.84%0.27%
Financial Health
Profit Margin (TTM) i0.01%0.24%
Operating Margin (TTM) i0.02%0.26%
Return on Equity (TTM) i0.05%0.15%
Debt to Equity (MRQ) i2,600.510.03
Cash & Liquidity
Book Value per Share (MRQ)₹1.07₹563.87
Cash per Share (MRQ)₹0.02₹132.86
Operating Cash Flow (TTM) i₹-16,381,918,000₹19.67B
Levered Free Cash Flow (TTM) i₹21.29M₹21.91B
Dividends
Last 12-Month Dividend Yield iN/A0.91%
Last 12-Month Dividend iN/A₹60.00

Valuation & Enterprise Metrics Analysis: Remedium Lifecare vs Divi's Laboratories

MetricREMLIFEDIVISLAB
Price Ratios
P/E Ratio (TTM) i25.1769.80
Forward P/E iN/A107.58
PEG Ratio i0.322.64
Price to Sales (TTM) i0.3016.66
Price to Book (MRQ) i1.4110.74
Market Capitalization
Market Capitalization i₹1.33B₹1.62T
Enterprise Value i₹12.80B₹1.56T
Enterprise Value Metrics
Enterprise to Revenue i2.9016.21
Enterprise to EBITDA i3,209.7351.05
Risk & Other Metrics
Beta i1.200.23
Book Value per Share (MRQ) i₹1.07₹563.87

Financial Statements Comparison: Remedium Lifecare vs Divi's Laboratories

Financial Metrics

Loading Financial Charts...

Revenue

EBITDA

Shareholders Equity

Operating Margin

Free Cash Flow

Long Term Debt

Profit Margin

Current Ratio

Operating Cash Flow

Income Statement (MRQ)

Metric (MRQ)REMLIFEDIVISLAB
Revenue/Sales i₹1.13B₹24.10B
Cost of Goods Sold i₹1.08B₹9.56B
Gross Profit i₹55.35M₹14.54B
Research & Development iN/AN/A
Operating Income (EBIT) i₹18.71M₹6.17B
EBITDA i₹18.71M₹8.48B
Pre-Tax Income i₹57.12M₹7.33B
Income Tax i₹10.64M₹1.88B
Net Income (Profit) i₹46.49M₹5.45B

Balance Sheet & Liquidity Metrics (MRQ)

Metric (MRQ)REMLIFEDIVISLAB
Cash & Equivalents i₹2.82M₹4.15B
Total Current Assets i₹17.20B₹100.81B
Total Current Liabilities i₹16.76B₹14.52B
Long-Term Debt i₹0₹20.00M
Total Shareholders Equity i₹438.91M₹149.69B
Retained Earnings iN/A₹134.00B
Property, Plant & Equipment i₹83,000₹3.19B

Cash Flow Statement Comparison (MRQ)

Metric (MRQ)REMLIFEDIVISLAB
Operating Cash Flow iN/AN/A
Capital Expenditures iN/AN/A
Free Cash Flow iN/AN/A
Debt Repayment iN/AN/A
Common Stock Repurchase iN/AN/A

Short Interest & Institutional Ownership Analysis

MetricREMLIFEDIVISLAB
Shares Short iN/AN/A
Short Ratio iN/AN/A
Short % of Float iN/AN/A
Average Daily Volume (10 Day) i13,810,708357,978
Average Daily Volume (90 Day) i8,468,759424,293
Shares Outstanding i577.65M265.47M
Float Shares i301.99M120.77M
% Held by Insiders i0.23%0.52%
% Held by Institutions i0.00%0.29%

Dividend Analysis & Yield Comparison: Remedium Lifecare vs Divi's Laboratories

MetricREMLIFEDIVISLAB
Last 12-Month Dividend iN/A₹60.00
Last 12-Month Dividend Yield iN/A0.91%
3-Year Avg Annual Dividend iN/A₹50.00
3-Year Avg Dividend Yield iN/A0.70%
3-Year Total Dividends iN/A₹150.00
Ex-Dividend DateN/AJul 25, 2025